Olive Oil With Omega 3 to Treat Stasis Dermatitis

NCT ID: NCT00421161

Last Updated: 2007-01-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE1/PHASE2

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2007-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Olive oil and Omega 3 have many anti inflammatory effects that may be beneficial in the inflammation and edema of chronic stasis dermatitis. The olive oil contains many mono unsaturated fatty acids and anti oxidants that may add to the well being of a diseased skin by improving cell membrane homeostasis.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients with chronic stasis dermatitis due to venous insufficiency will be treated with the study cream and as control we will use "Venoroutone" . Patients will be followed weekly at the clinic of the vascular surgery at Assaf Harofeh MC.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

olive oil and omega 3 in a combined cream

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patints with stasis dermatitis for 6 months at least

Exclusion Criteria

* skin ulceration or infection
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assaf-Harofeh Medical Center

OTHER_GOV

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arie Bass, MD

Role: PRINCIPAL_INVESTIGATOR

Assaf Harofe MC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Assaf Harofe MC

Ẕerifin, Beer Yaacov, Israel

Site Status

Clinic of vascular surgery, Assaf Harofe MC

Ẕerifin, Zerifin, Israel

Site Status

Clinic of Vascular Surgery

Ẕerifin, Zerifin, Israel

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Refael Segal, MD, Prof'

Role: CONTACT

972-8-9258640-3

Arie Bas, MD, Prof

Role: CONTACT

972-8-9779188

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Refael Segal, MD

Role: primary

972-8-9258640-3

Refael Segal, MD

Role: primary

972-8-9258640-3

References

Explore related publications, articles, or registry entries linked to this study.

Sapino S, Carlotti ME, Peira E, Gallarate M. Hemp-seed and olive oils: their stability against oxidation and use in O/W emulsions. J Cosmet Sci. 2005 Jul-Aug;56(4):227-51.

Reference Type BACKGROUND
PMID: 16130045 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Refael Segal

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.